Wegovy Pill Gives Australians a Weight-Loss Alternative
Doctors in Australia can now prescribe Wegovy as a daily pill, offering an alternative to weekly injections. The tablet is expected to cost $260 to $395 a month, depending on the dose. A second oral weight-management drug, Foundayo, has also been approved.

Australian doctors can now prescribe the Wegovy diet pill for weight management, giving patients an alternative to weekly injections. Novo Nordisk's daily tablet is expected to cost $260 to $395 a month, depending on the dose. The injectable version costs $350 to $500 a month.
The Australian Therapeutic Goods Administration approved the Wegovy pill earlier in the month. The drug is now available in pharmacies.
The approval calls for the pill to be prescribed alongside a reduced-calorie diet and increased physical activity for chronically overweight adults.
Wegovy belongs to a class of medicines known as GLP-1 drugs. Until now, Wegovy and other weight-loss drugs such as Ozempic and Mounjaro were available only as injections in Australia.
Research by UNSW Medicine and Health found that 500,000 Australians were using GLP-1 injections as of mid-2025.
Two pills offer different options
Rival manufacturer Lilly has also received approval to sell Foundayo, a prescription GLP-1 pill whose active substance is orforglipron. Lilly said stocks would enter Australia “in the coming days.”
The medicines have different instructions for use. Obesity expert Terri-Lynne South said patients must take oral Wegovy on an empty stomach with no more than a small sip of water.
They must then wait at least 30 minutes before eating, drinking or taking other medicines, South said. Foundayo has no food or water restrictions on when it can be taken.
Wegovy injections also need refrigeration. South said tablets could remove a barrier for some patients who fear injections or face practical difficulties with travel and refrigeration.
“A daily tablet may help some patients who would otherwise not have started treatment,” South said.
Specialist GP Remon Eskandar said some patients were uncomfortable with injections for cultural, practical or stigma-related reasons. An oral tablet gives those patients another choice, he said.
Diet and subsidy questions remain
Elizabeth Lou, a dietitian at meal parcel company Marley Spoon, said GLP-1 medicines do not remove the need for diet and exercise.
Lou recommended nutrient-dense foods, including fish, eggs, lean red meat, vegetables and legumes, to help preserve muscle mass and meet essential nutrient needs.
Federal health officials have sought to add weight-loss drugs to the Pharmaceutical Benefits Scheme, Australia's drug subsidy program.
In August, Federal Health Minister Mark Butler said subsidies would focus on people with “established cardiovascular diseases” and a high BMI if an agreement could be reached with drug companies.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Lifestyle · Food & HealthNormal Blood Pressure Chart by Age: Healthy Ranges Explained
Lifestyle · Food & HealthWhat Is Raynaud’s Syndrome? Why Fingers Turn White in the Cold
Lifestyle · Food & Health4 Ways Walking After Meals Helps Your Body, Doctors Say
Lifestyle · Food & Health4 Reasons to Eat Oatmeal, According to Nutrition Experts



















